December 5, 2021
Report

Evaluation of Three RNA Extraction Kits with a 2019-nCoV Assay

Abstract

The following characteristics of three RNA extraction kits (Norgen Biotek Total RNA Purification Kit, #17200; Bioneer AccuPrep Viral RNA Extraction Kit, #K-3033; and Promega Maxwell HT Viral TNA Kit, #AX2340) were evaluated: • Limits of detection for quantitative synthetic RNA using the Centers for Disease Control and Prevention’s (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel and the Applied Biosystems 7500 Fast Dx system; • Limits of detection for positive clinical specimen using the Centers for Disease Control and Prevention’s (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel and the Applied Biosystems 7500 Fast Dx system; • Ability of the lysis buffers in each kit to inactivate the virus as measured by a cell-based infectivity assay.

Published: December 5, 2021

Citation

Omberg K.M., H.E. Engelmann, J.R. Hutchison, A.M. Melville, K.L. Oxford, and K.D. Victry. 2020. Evaluation of Three RNA Extraction Kits with a 2019-nCoV Assay Richland, WA: Pacific Northwest National Laboratory.

Research topics